South Korea · Delayed Price · Currency is KRW MedPacto Statistics
Total Valuation
MedPacto has a market cap or net worth of KRW 114.14 billion. The enterprise value is 77.97 billion.
| Market Cap | 114.14B |
| Enterprise Value | 77.97B |
Important Dates
The next estimated earnings date is Monday, August 10, 2026.
| Earnings Date | Aug 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MedPacto has 34.28 million shares outstanding. The number of shares has increased by 2.21% in one year.
| Current Share Class | 34.28M |
| Shares Outstanding | 34.28M |
| Shares Change (YoY) | +2.21% |
| Shares Change (QoQ) | -0.27% |
| Owned by Insiders (%) | 11.97% |
| Owned by Institutions (%) | 0.34% |
| Float | 25.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 23.85 |
| PB Ratio | 2.68 |
| P/TBV Ratio | 2.72 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 16.29 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 26.54, with a Debt / Equity ratio of 0.04.
| Current Ratio | 26.54 |
| Quick Ratio | 25.20 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.12 |
| Interest Coverage | -100.17 |
Financial Efficiency
Return on equity (ROE) is -27.18% and return on invested capital (ROIC) is -18.22%.
| Return on Equity (ROE) | -27.18% |
| Return on Assets (ROA) | -17.81% |
| Return on Invested Capital (ROIC) | -18.22% |
| Return on Capital Employed (ROCE) | -32.91% |
| Weighted Average Cost of Capital (WACC) | 5.12% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.09 |
| Inventory Turnover | 10.99 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.37% in the last 52 weeks. The beta is 0.15, so MedPacto's price volatility has been lower than the market average.
| Beta (5Y) | 0.15 |
| 52-Week Price Change | -12.37% |
| 50-Day Moving Average | 4,731.50 |
| 200-Day Moving Average | 5,376.15 |
| Relative Strength Index (RSI) | 29.49 |
| Average Volume (20 Days) | 179,010 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MedPacto had revenue of KRW 4.79 billion and -13.21 billion in losses. Loss per share was -383.81.
| Revenue | 4.79B |
| Gross Profit | 536.20M |
| Operating Income | -14.41B |
| Pretax Income | -13.21B |
| Net Income | -13.21B |
| EBITDA | -13.31B |
| EBIT | -14.41B |
| Loss Per Share | -383.81 |
Balance Sheet
The company has 37.79 billion in cash and 1.62 billion in debt, with a net cash position of 36.17 billion or 1,055.19 per share.
| Cash & Cash Equivalents | 37.79B |
| Total Debt | 1.62B |
| Net Cash | 36.17B |
| Net Cash Per Share | 1,055.19 |
| Equity (Book Value) | 42.58B |
| Book Value Per Share | 1,245.66 |
| Working Capital | 40.28B |
Cash Flow
In the last 12 months, operating cash flow was -12.92 billion and capital expenditures -132.52 million, giving a free cash flow of -13.05 billion.
| Operating Cash Flow | -12.92B |
| Capital Expenditures | -132.52M |
| Depreciation & Amortization | 1.10B |
| Net Borrowing | -643.58M |
| Free Cash Flow | -13.05B |
| FCF Per Share | -380.86 |
Margins
Gross margin is 11.21%, with operating and profit margins of -301.14% and -276.11%.
| Gross Margin | 11.21% |
| Operating Margin | -301.14% |
| Pretax Margin | -276.11% |
| Profit Margin | -276.11% |
| EBITDA Margin | -278.16% |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MedPacto does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.21% |
| Shareholder Yield | -2.21% |
| Earnings Yield | -11.58% |
| FCF Yield | -11.44% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 13, 2020. It was a forward split with a ratio of 2.
| Last Split Date | May 13, 2020 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
MedPacto has an Altman Z-Score of 29.49 and a Piotroski F-Score of 3.
| Altman Z-Score | 29.49 |
| Piotroski F-Score | 3 |